Cargando...
Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
OBJECTIVE: To identify potential drug interactions (DIs) between pangenotypic direct-acting antivirals (pDAAs) and concomitant cardiovascular (CV) therapies in patients with chronic hepatitis C (CHC). METHODS: A retrospective observational study was carried out. Patients ≥18 years of age diagnosed w...
Gardado en:
| Publicado en: | J Int Med Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645390/ https://ncbi.nlm.nih.gov/pubmed/33111612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520964659 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|